Burning Rock Biotech (NASDAQ:
BNR) reported quarterly losses of $(0.20) per share. This is a 87.5 percent increase over losses of $(1.60) per share from the same period last year. The company reported $18.34 million in sales this quarter. This is a 5.41 percent increase over sales of $17.40 million the same period last year.